DK1865931T3 - Transdermal plaster - Google Patents

Transdermal plaster

Info

Publication number
DK1865931T3
DK1865931T3 DK06725214.8T DK06725214T DK1865931T3 DK 1865931 T3 DK1865931 T3 DK 1865931T3 DK 06725214 T DK06725214 T DK 06725214T DK 1865931 T3 DK1865931 T3 DK 1865931T3
Authority
DK
Denmark
Prior art keywords
transdermal patch
nitroglycerin
administration
transdermal
patch
Prior art date
Application number
DK06725214.8T
Other languages
English (en)
Inventor
Paola Stefanelli
Sergio Comuzio
Original Assignee
Bouty S P A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bouty S P A filed Critical Bouty S P A
Application granted granted Critical
Publication of DK1865931T3 publication Critical patent/DK1865931T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061Polyacrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Cardiology (AREA)
  • Emergency Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
DK06725214.8T 2005-03-23 2006-03-22 Transdermal plaster DK1865931T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT000477A ITMI20050477A1 (it) 2005-03-23 2005-03-23 Cerotto transdermico
PCT/EP2006/060930 WO2006100251A1 (en) 2005-03-23 2006-03-22 Transdermal patch

Publications (1)

Publication Number Publication Date
DK1865931T3 true DK1865931T3 (da) 2011-12-05

Family

ID=35262212

Family Applications (1)

Application Number Title Priority Date Filing Date
DK06725214.8T DK1865931T3 (da) 2005-03-23 2006-03-22 Transdermal plaster

Country Status (15)

Country Link
US (1) US9549902B2 (da)
EP (1) EP1865931B1 (da)
JP (1) JP2008534474A (da)
AT (1) ATE524167T1 (da)
AU (1) AU2006226348A1 (da)
BR (1) BRPI0609451A2 (da)
CA (1) CA2602534C (da)
DK (1) DK1865931T3 (da)
ES (1) ES2373401T3 (da)
IT (1) ITMI20050477A1 (da)
MX (1) MX2007011681A (da)
PL (1) PL1865931T3 (da)
PT (1) PT1865931E (da)
RU (1) RU2420269C2 (da)
WO (1) WO2006100251A1 (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012094360A2 (en) 2011-01-04 2012-07-12 Gordon Chiu Biotherapeutics for the treatment of infectious diseases
US9044390B1 (en) 2014-04-17 2015-06-02 Gary J. Speier Pharmaceutical composition and method of manufacturing
US9186386B2 (en) 2014-04-17 2015-11-17 Gary J. Speier Pharmaceutical composition and method of manufacturing
JP6650730B2 (ja) * 2015-10-22 2020-02-19 日東電工株式会社 超小型固定用テープおよびそれを含む物品
CA3013123A1 (en) 2016-02-04 2017-08-10 Cinrx Pharma, Llc Deuterated domperidone compositions and methods for therapy of disorders
US11364226B2 (en) 2017-06-30 2022-06-21 Cinrx Pharma, Llc Deuterated domperidone compositions, methods, and preparation
WO2024006305A1 (en) * 2022-06-27 2024-01-04 Permeatus, Inc. Topical formulations of nitroglycerin
CN117653610B (zh) * 2023-09-28 2024-07-05 海南卓科制药有限公司 一种硝酸甘油片及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU561608B1 (en) * 1985-11-04 1987-05-14 Paco Research Corp. Transdermal vasoactive delivery
US5474783A (en) * 1988-03-04 1995-12-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
US5202125A (en) * 1990-12-10 1993-04-13 Theratech, Inc. Method and systems for administering nitroglycerin transdermally at enhanced transdermal fluxes
IT1294748B1 (it) * 1997-09-17 1999-04-12 Permatec Tech Ag Formulazione per un dispositivo transdermico

Also Published As

Publication number Publication date
BRPI0609451A2 (pt) 2010-04-06
PL1865931T3 (pl) 2012-02-29
EP1865931B1 (en) 2011-09-14
RU2007139110A (ru) 2009-04-27
JP2008534474A (ja) 2008-08-28
ATE524167T1 (de) 2011-09-15
US9549902B2 (en) 2017-01-24
CA2602534A1 (en) 2006-09-28
AU2006226348A1 (en) 2006-09-28
WO2006100251A1 (en) 2006-09-28
MX2007011681A (es) 2008-01-28
RU2420269C2 (ru) 2011-06-10
ES2373401T3 (es) 2012-02-03
EP1865931A1 (en) 2007-12-19
ITMI20050477A1 (it) 2006-09-24
US20090028929A1 (en) 2009-01-29
PT1865931E (pt) 2012-01-05
CA2602534C (en) 2015-05-05

Similar Documents

Publication Publication Date Title
DK1865931T3 (da) Transdermal plaster
CY1111729T1 (el) Υπογλωσσιο επικαλυμμενο δισκιο
BRPI0809366A8 (pt) polipeptídeos interligados
BRPI0508894A (pt) meios para administração transdérmica de nicotina e uso
DK2058020T3 (da) Indretning til indgivelse af lægemiddel
IS7997A (is) Granisetron lyfjaplástur
EA201070786A1 (ru) Бензофуропиримидиноны
CR10157A (es) Compuestos químicos
DK2117521T3 (da) Transdermale indgivelsessystemer omfattende bupivacain
DK1812895T3 (da) Stofkilde
MX2007015424A (es) Formulaciones ungueales topicas.
CY1113024T1 (el) Σπειροκυκλικα παραγωγα κυκλοεξανιου για τη θεραπεια της εξαρτησης ουσιων
CL2008002295A1 (es) Compuestos derivados de tiazolida sustituidos con alquilsulfonilos; composicion farmaceutica; y uso para el tratamiento de la hepatitis c.
ECSP066883A (es) Derivados de heteroarilaminopirazol utiles para el tratamiento de la diabetes
HN2006037713A (es) Compuestos utiles en terapia
ME01459B (me) Postupak za doziranje medikamenata
ATE506340T1 (de) 12-aryl-prostaglandin-analoga
DK2204146T3 (da) Fodtøjsortose
AT500095B8 (de) Transdermales abgabesystem
BRPI0716643A2 (pt) amidas terapêuticas e compostos relacionados
EA201000439A1 (ru) Бензотиазолы в качестве модуляторов рецептора грелина
NO20063293L (no) Farmasoytiske forbindelser
UY30801A1 (es) Compuestos calciliticos
PA8646301A1 (es) Inhibidores de la adenilato ciclasa soluble
SM200400022B (it) Composti farmaceutici transdermici